CRBP

CORBUS PHARMACEUTICALS HOLDI

CRBP·21833P103·UQ·Common Stock·Healthcare - Biotechnology-13D/G

CRBP (CORBUS PHARMACEUTICALS HOLDI) is held by 58 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($12.5M), Aberdeen Group plc ($12.4M), VANGUARD CAPITAL MANAGEMENT LLC ($7.1M). Net institutional sentiment: Mixed.

58
Holders
(3 Elite)
$59.9M
Total Value
53% (62)
Consensus
33 buying - 29 selling
13F: Insider & Congress: Updated regularly
CRBP

Smart Money Verdict

View all
Loading verdict
Held by 58 funds
3 elite

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Sep 15, 2026 · Activists Sep 30, 2026 · Congress none

ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%Sep 30, 2026
InsiderBYBen YongSell $16KSep 14, 2026
InsiderNVNicacio Leonardo VianaVest 58K shAug 16, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
1.3M(+390.0%)$12.5M0.0%-46.20%
45
Unchanged
1.3M$12.4M0.0%-39.40%
0
Increased
760,940(+3.7%)$7.1M0.0%-36.13%
28
Increased
423,374(+126.4%)$4M0.0%-74.48%
43
Decreased
293,203(-12.1%)$2.8M0.0%-43.42%
0
Increased
254,672(+269.8%)$2.4M0.0%-66.14%
42
Increased
190,214(+39.3%)$1.8M0.0%-37.70%
34
Decreased
151,640(-5.5%)$1.4M0.0%-67.26%
0
Increased
139,133(+90.1%)$1.3M0.0%-47.99%
40
Increased
124,906(+200.9%)$1.2M0.0%-58.11%
41
Increased
112,397(+16.8%)$1.1M0.0%-37.10%
29
Increased
111,302(+356.8%)$1M0.0%-42.24%
28
Decreased
110,822(-68.1%)$1M0.0%-35.58%
0
Decreased
92,154(-87.3%)$864,4050.0%-34.21%
0
Decreased
79,331(-45.9%)$744,1250.0%-46.52%
0
Increased
78,120(+644.8%)$732,7660.0%-42.87%
40
Increased
67,654(+77.9%)$634,5950.0%-39.58%
37
Decreased
62,863(-32.5%)$589,6550.0%-71.38%
0
New
55,455$520,1680.0%-43.82%
33
New
55,224$504,7470.0%-43.82%
33

Showing 1-20 of 71

1 / 4
CRBPCRBPCORBUS PHARMACEUTICALS HOLDI

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used